Furthermore, at that time, it was recognized that most thyroid papillary carcinomas express CD44, and it was suggested to have clinical value in confirming the diagnosis of malignancy when fine‐needle aspiration specimens were used [37]. This evidence concerns the gene CD44 and thyroid gland papillary carcinoma.